The simplest explanation for the increased anxiety induced by loperamide in females is that the activation of peripheral mu opioid receptors inhibited ENS firing and vagal afferent firing and reduced activation of brain pathways associated with GABA inhibition (and possibly the neuroimmune axis), promoting neural excitation and leading to increased anxiety. The gene discussed is OPRM1; the disease is Anxiety.